Aditya Kulkarni

Aditya Kulkarni, PhD, is a Senior Clinical Scientist at BlossomHill Therapeutics, Inc., with extensive experience in early-phase oncology trials at Lantern Pharma Inc., where notable contributions included leading clinical strategy and authoring regulatory submissions. Previous roles at Lantern included Senior Research Scientist & Program Manager and Lead Scientist & Program Manager, emphasizing collaboration across various scientific and operational functions. Aditya's research background includes a postdoctoral role at UT Southwestern Medical Center, focusing on differential drug toxicity in non-small cell lung cancer, and a solid academic foundation with a Ph.D. in Biochemistry and Molecular Biology from Baylor College of Medicine. Early experience includes a Bachelor's degree in Pharmaceutical Sciences and Technology from the Institute of Chemical Technology and internships in drug formulation and quality control.